Patents by Inventor Marius Tuijnder

Marius Tuijnder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
    Patent number: 8206916
    Abstract: A device and kit for pulsing a biological sample with a pulsing agent is disclosed. The biological sample so pulsed is subsequently stabilized and the device or kit provides a control reaction. Applications for the described device and kit are found in the field of medical diagnostics, particularly immunology.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: June 26, 2012
    Assignee: Universite Libre de Bruxelles
    Inventors: Patrick Stordeur, Michel Goldman, Marius Tuijnder
  • DEVICE, KIT AND METHOD FOR PULSING BIOLOGICAL SAMPLES WITH AN AGENT AND STABILISING THE SAMPLE SO PULSED
    Publication number: 20110263007
    Abstract: A device and kit for pulsing a biological sample with a pulsing agent is disclosed. The biological sample so pulsed is subsequently stabilized and the device or kit provides a control reaction. Applications for the described device and kit are found in the field of medical diagnostics, particularly immunology.
    Type: Application
    Filed: April 15, 2011
    Publication date: October 27, 2011
    Applicant: Universite Libre de Bruxelles
    Inventors: Patrick Stordeur, Michel Goldman, Marius Tuijnder
  • Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
    Patent number: 7947450
    Abstract: A device and kit for pulsing a biological sample with a pulsing agent is disclosed. The biological sample so pulsed is subsequently stabilized and the device or kit provides a control reaction. Applications for the described device and kit are found in the field of medical diagnostics, particularly immunology.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: May 24, 2011
    Assignee: Universite Libre de Bruxelles
    Inventors: Patrick Stordeur, Michel Goldman, Marius Tuijnder
  • DEVICE, KIT AND METHOD FOR PULSING BIOLOGICAL SAMPLES WITH AN AGENT AND STABILISING THE SAMPLE SO PULSED
    Publication number: 20090117646
    Abstract: A device and kit for pulsing a biological sample with a pulsing agent is disclosed. The biological sample so pulsed is subsequently stabilized and the device or kit provides a control reaction. Applications for the described device and kit are found in the field of medical diagnostics, particularly immunology.
    Type: Application
    Filed: October 17, 2008
    Publication date: May 7, 2009
    Applicant: Universite Libre de Bruxelles
    Inventors: Patrick Stordeur, Michel Goldman, Marius Tuijnder
  • Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
    Publication number: 20050221303
    Abstract: This invention is directed to sequences that are involved in the molecular pathways of tumor suppression, tumor revision, apoptosis and/or virus resistance. The use of the compounds having these sequences, or encoded by them, in treating cancer, neurodegenerative diseases or viral diseases, and screening methods for compounds having such therapeutic properties are also encompassed.
    Type: Application
    Filed: February 13, 2002
    Publication date: October 6, 2005
    Inventors: Adam Telerman, Robert Amson, Marius Tuijnder, Laurent Susini
  • Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines
    Publication number: 20040241671
    Abstract: This invention is directed to sequences that are involved in the molecular pathways of tumor suppression, tumor reversion, apoptosis and/or virus resistance. The use of the compounds having these sequences, or encoded by them, in treating cancer, neurodegenerative diseases or viral diseases, and screening methods for compounds having such therapeutic properties are also encompassed.
    Type: Application
    Filed: April 14, 2004
    Publication date: December 2, 2004
    Inventors: Adam Telerman, Robert Amson, Marius Tuijnder, Laurent Susini
  • Compositions and methods for the treatment of cancer
    Publication number: 20040087531
    Abstract: Composition and methods of treating, preventing, and managing cancer by inhibiting the expression of the gene tpt1 are disclosed. In addition, a method of identifying genes that are involved in the tumor reversion of two or more types of cancers is also disclosed.
    Type: Application
    Filed: May 16, 2003
    Publication date: May 6, 2004
    Inventors: Adam Telerman, Robert Amson, Marius Tuijnder, Laurent Susini
  • Methods and compositions for the treatment of cancer
    Publication number: 20040072824
    Abstract: Methods of treating and managing cancer are disclosed, which comprise the administration of an antihistaminic agents or structurally/functionally related to compound, optionally in combination with one or more additional anti-cancer agents. Pharmaceutical compositions, including single unit dosage forms, and kits useful in the treatment and management of cancer are disclosed. Also disclosed is a method of determining effectiveness of a cancer treatment.
    Type: Application
    Filed: March 12, 2003
    Publication date: April 15, 2004
    Inventors: Adam Telerman, Robert Amson, Marius Tuijnder
  • Drugs which can be used in the treatment of cancer
    Publication number: 20030087900
    Abstract: The present invention relates to the use of a compound inhibiting the expression of the TPT1 gene, or of the products which it controls, for producing a drug which is intended for treating cancer.
    Type: Application
    Filed: November 27, 2002
    Publication date: May 8, 2003
    Applicant: Molecular Engines Laboratories
    Inventors: Adam Telerman, Robert Amson, Marius Tuijnder
  • Drugs which can be used in the treatment of cancer
    Publication number: 20020193371
    Abstract: The present invention relates to the use of a compound inhibiting the expression of the TPT1 gene, or of the products which it controls, for producing a drug which is intended for treating cancer.
    Type: Application
    Filed: June 20, 2001
    Publication date: December 19, 2002
    Inventors: Adam Telerman, Robert Amson, Marius Tuijnder